A black inverted triangle '▼' will shortly appear on the package leaflet of certain medicinal products on the EU market, following an Implementing Regulation adopted by the European Commission today. This symbol will flag to patients and health care professionals that a medicinal product is subject to additional monitoring, and its accompanying text will encourage them to report any unexpected adverse reaction through national reporting systems.
Our latest News Update is here!
A clinical trial to evaluate a new therapeutic treatment using eye drops for the early stages of diabetic retinopathy started this week, researchers announced. A group of leading European ophthalmologists, endocrinologists and researchers have gathered together under EUROCONDOR, the European Consortium on the early treatment of diabetic retinopathy, and will conduct the clinical trial in 11 clinical centres across the EU.
The January IDF Europe News Update is here.
For the 3rd edition of its Youth Leadership Camp to be organized during the summer of 2013, IDF Europe has published a call for European Diabetes Associations to propose a camp venue.